about us | newsletter | contact | archive | members area
BOGDAN ANDRIESCU, UNSICAR
Digital innovation will lead to more regulations that will put pressure on companies for»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  2000 Views
Daily Info
Dragnea: There is no risk of PSD getting destabilized

Leader of the Social Democratic Party (PSD) Liviu Dragnea told a private broadcaster on Sunday that there is no risk of his party getting destabilised as he and the incumbent ...

Cristian Covaciu, founder of IPEC, nominated EY Entrepreneur of the Year 2016 in Romania

Cristian Covaciu, founder of IPEC company, was nominated the winner of EY Entrepreneur of the Year 2016 competition and will represent Romania at the world final in Monte Carl...

PM Grindeanu wishes for 2019 with no CVM for Romania

Premier Sorin Grindeanu stated, on Thursday, at the headquarters of the European Commission, that he wishes in 2019 the Cooperation and Verification Mechanism (CVM) for Romani...

Three office buildings to be developed by Iulius in Timisoara

This spring, the Iulius company will start the construction works for three new class A office buildings within the Openville Timisoara mixed-use project, located near Iulius ...

UPC Romania revenues increased by nine per cent last year

UPC Romania, part of Liberty Global group, has seen an increase of 8.8 per cent in terms of revenues in 2016, up to 689.3 million RON (153 million Euro) according to Robert Re...

 
 
   
advertising

advertising

advertising

advertising

More on News
Energy Performance Contracting for public buildings

The Romanian Association for Promoting Energy Efficiency (ARPEE), established in 2012, has as overall scope the mobilization of its members’ resources and competences to ...

Ciolos: Progress in anti-corruption fight can no longer be wiped off through ordinances dedicated to politicians

The progress made in the fight against corruption can no longer be wiped out surreptitiously through emergency ordinances "dedicated to a handful of politicians," former Pr...

EU seals trade deal with Canada

The European Parliament voted in favour of the Comprehensive Economic and Trade Agreement (CETA) between the EU and Canada, concluding the ratification process of this deal...

President Iohannis wants to address Parliament on 7 February

President Klaus Iohannis sent a letter to the Heads of the two Chambers of the Legislature, in which he reveals that he wants to address Parliament on 7 February, in respec...

Iohannis at Government meeting: I discussed with the PM; I am pleased with how you do your job

President Klaus Iohannis said on Wednesday he had, before the Government meeting, a "very applied" discussion with Prime Minister Sorin Grindeanu, and the head of state tol...

Iohannis: 2017 budget is a problematic and risky one

President Klaus Iohannis said that the budget draft for 2017 is a problematic and risky one, pointing that there is the real risk for the deficit of three percent to be exc...

PM Grindeanu: We support our views on 2017 budget

The Government will support its views in respect to the 2017 budget draft in the Supreme Council for National Defence (CSAT) meeting on Tuesday, Prime Minister Sorin Grinde...